Abstract Novel coronavirus disease 2019 (COVID‐19) poses a global threat, due to its
fluctuating frequency and lethality. Published data revealed associations of COVID‐19 …

Although advanced age and presence of comorbidities significantly impact the variation
observed in the clinical symptoms of COVID-19, it has been suggested that genetic variants …

Although advanced age, male sex, and some comorbidities impact the clinical course of
COVID-19, these factors only partially explain the inter-individual variability in disease …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been responsible for
the recent pandemic since early 2020. Due to the wide range of clinical symptoms of this …

The advent and persistence of the Severe Acute Respiratory Syndrome Coronavirus–2
(SARS-CoV-2)-induced Coronavirus Disease (COVID-19) pandemic since December 2019 …

Patients with viral illness are at higher risk of secondary infections—whether bacterial, viral,
or parasitic—that usually lead to a worse prognosis. In the setting of Corona Virus Disease …

Hypertension, diabetes mellitus, and coronary artery disease are common comorbidities and
dangerous factors for infection and serious COVID-19. Polymorphisms in genes associated …

Abstract Coronavirus disease 2019 (COVID‐19), caused by a highly pathogenic emerging
virus, is called severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Knowledge …

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into
a global pandemic, with an alarming infectivity and mortality rate. Studies have examined …

Background and aim: Gene polymorphism, coding the host proteases, which are involved in
the virus entry into the cells can influence the susceptibility to and mortality from coronavirus …